From rejection to revolution: mRNA vaccines go beyond infections to diseases in the brain
Dr. Elias Sayour describes his groundbreaking research to find new treatments for glioblastoma for Inside Precision Medicine.
Posted in
Brain Cancer News
Cancer vaccines are showing promise at last
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
MBI researcher named 2024 Innovator of the Year
Dr. Elias Sayour earns honor from UF Innovate | Tech Licensing for his work in brain cancer immunotherapy.
Tech Tuesday: Brain cancer vaccines
Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.
Gene therapy method may enhance effectiveness of immunotherapy for glioblastoma
Dr. Christina von Roemeling and colleagues have developed a novel strategy to deliver genetic material directly to cells associated with glioblastoma.
UF researchers to test novel treatments for medulloblastoma
First-ever human clinical trials of new experimental treatments for Group 4 medulloblastoma to begin at UF this fall.
MBI members honored at College of Medicine spring faculty assembly
Dr. David Borchelt (Lifetime Achievement Award, pictured below) and Dr. Maryam Rahman (collegewide Clinical Excellence Award) among awardees.
Media coverage of mRNA brain cancer vaccine trial
See media highlights stemming from May 9 paper published in the journal Cell.
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
Vaccine triggers fierce response to fight brain tumor
UF-developed mRNA vaccine quickly reprogrammed the immune system to attack glioblastoma.
